US Corporate Controller

من الإعلان الأصلي

New York G&A - 30000 - Finance About us Hansa Biopharma is a fast-growing, commercial-stage biopharmaceutical company, pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with acute or complex immune disorders. Our broad therapeutic pipeline based on the company’s proprietary IgG-cleaving enzyme technology platform has potential to address serious unmet medical needs in autoimmune diseases, gene therapy, and transplantation. By empowering our people we move our projects forward with high speed, efficiency and scientific…